A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only

NCT00451178 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: enzastaurin
DRUG: rituximab
DRUG: cyclophosphamide
DRUG: doxorubicin
DRUG: vincristine
DRUG: prednisone

Sponsor

Eli Lilly and Company